Pneumonia, not cytokine storm, a key driver of COVID-19 deaths: study … Assisted living held up as solution to ‘loneliness epidemic’ … CDC: Cigarette smoking at its lowest since 1965, least common...
Long-term care’s zeal for foreign nurses a ‘Band-Aid’ solution: researchers
By
Kimberly Marselas
May 05, 2023
In a new commentary, researchers likened long-term care organizations’ quest to entice immigrant nurses to using a Band-Aid to stop a hemorrhaging workforce wound.
Deep sleep may buffer against memory loss in those with Alzheimer’s brain changes: study
By
Alicia Lasek
May 05, 2023
Deep sleep may help build cognitive reserve, increasing resilience against the effects of beta-amyloid brain changes, investigators report.
BMJ study: Medical cannabis safely relieves cancer pain, cuts total meds count
By
Alicia Lasek
May 05, 2023
Medicinal cannabis is a safe treatment for cancer pain, and its use may help reduce reliance on other pain medications, a new study finds.
Reducing dietary saturated fat cuts mortality risk by 18 percent in older adults: study
By
Alicia Lasek
May 05, 2023
Study participants who consumed the most healthy, low-fat diets relative to their peers had 18% fewer deaths from all causes and lower deaths from cardiovascular disease and cancer, researchers report.
Clinical briefs for Friday, May 5
By
Alicia Lasek
May 05, 2023
Effective nursing home IPC programs need owner buy-in, quality experts say … Updated: 2023 AGS Beers Criteria for potentially inappropriate meds in older adults … WHO releases hand hygiene campaign...
First-ever RSV vaccine to get FDA nod is approved for adults age 60+
By
Alicia Lasek
May 04, 2023
Arexvy has shown 82.6% efficacy against the development of lower respiratory tract disease caused by the virus, developer GSK reports.
Alzheimer’s drug donanemab finds late-stage trial success, safety concerns
By
Alicia Lasek
May 04, 2023
The experimental drug donanemab appears to halt the progression of Alzheimer’s disease and slow certain measures of clinical decline, new trial data show.
Beta blockers seem not to reduce risks more than one year after heart attack
May 04, 2023
Long-term beta blocker therapy was not associated with improved cardiovascular outcomes during a median follow-up period of 4.5 years, investigators report.
Clinical briefs for Thursday, May 4
By
Alicia Lasek
May 04, 2023
Providers tepidly embrace CMS plan to revoke ‘no longer needed’ vax mandate … Pandemic taking toll on RNs’ job satisfaction, mental health, survey finds … Survey reveals reasons behind older...